These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
518 related articles for article (PubMed ID: 16555063)
1. Effect of methamphetamine self-administration on tyrosine hydroxylase and dopamine transporter levels in mesolimbic and nigrostriatal dopamine pathways of the rat. Shepard JD; Chuang DT; Shaham Y; Morales M Psychopharmacology (Berl); 2006 May; 185(4):505-13. PubMed ID: 16555063 [TBL] [Abstract][Full Text] [Related]
2. Contrasting effects of repeated treatment vs. withdrawal of methamphetamine on tyrosine hydroxylase messenger RNA levels in the ventral tegmental area and substantia nigra zona compacta of the rat brain. Zhang Y; Angulo JA Synapse; 1996 Nov; 24(3):218-23. PubMed ID: 8923661 [TBL] [Abstract][Full Text] [Related]
3. Aripiprazole differentially affects mesolimbic and nigrostriatal dopaminergic transmission: implications for long-term drug efficacy and low extrapyramidal side-effects. Han M; Huang XF; Deng C Int J Neuropsychopharmacol; 2009 Aug; 12(7):941-52. PubMed ID: 19203411 [TBL] [Abstract][Full Text] [Related]
4. Reduced gene expression for dopamine biosynthesis and transport in midbrain neurons of adult male rats exposed prenatally to ethanol. Szot P; White SS; Veith RC; Rasmussen DD Alcohol Clin Exp Res; 1999 Oct; 23(10):1643-9. PubMed ID: 10549997 [TBL] [Abstract][Full Text] [Related]
5. Extended methamphetamine self-administration in rats results in a selective reduction of dopamine transporter levels in the prefrontal cortex and dorsal striatum not accompanied by marked monoaminergic depletion. Schwendt M; Rocha A; See RE; Pacchioni AM; McGinty JF; Kalivas PW J Pharmacol Exp Ther; 2009 Nov; 331(2):555-62. PubMed ID: 19648469 [TBL] [Abstract][Full Text] [Related]
6. Epothilone D prevents binge methamphetamine-mediated loss of striatal dopaminergic markers. Killinger BA; Moszczynska A J Neurochem; 2016 Feb; 136(3):510-25. PubMed ID: 26465779 [TBL] [Abstract][Full Text] [Related]
7. Selective vulnerability in striosomes and in the nigrostriatal dopaminergic pathway after methamphetamine administration : early loss of TH in striosomes after methamphetamine. Granado N; Ares-Santos S; O'Shea E; Vicario-Abejón C; Colado MI; Moratalla R Neurotox Res; 2010 Jul; 18(1):48-58. PubMed ID: 19760475 [TBL] [Abstract][Full Text] [Related]
8. Acute methamphetamine administration increases tyrosine hydroxylase mRNA levels in the rat locus coeruleus. Shishido T; Watanabe Y; Matsuoka I; Nakanishi H; Niwa S Brain Res Mol Brain Res; 1997 Dec; 52(1):146-50. PubMed ID: 9450687 [TBL] [Abstract][Full Text] [Related]
9. Effect of the weaver mutation on the expression of dopamine membrane transporter, tyrosine hydroxylase and vesicular monoamine transporter in dopaminergic neurons of the substantia nigra and the ventral tegmental area. Adelbrecht C; Agid Y; Raisman-Vozari R Brain Res Mol Brain Res; 1996 Dec; 43(1-2):291-300. PubMed ID: 9037545 [TBL] [Abstract][Full Text] [Related]
10. Extended access to methamphetamine self-administration up-regulates dopamine transporter levels 72 hours after withdrawal in rats. D'Arcy C; Luevano JE; Miranda-Arango M; Pipkin JA; Jackson JA; Castañeda E; Gosselink KL; O'Dell LE Behav Brain Res; 2016 Jan; 296():125-128. PubMed ID: 26367473 [TBL] [Abstract][Full Text] [Related]
14. Adrenalectomy counteracts the local modulation of astroglial fibroblast growth factor system without interfering with the pattern of 6-OHDA-induced dopamine degeneration in regions of the ventral midbrain. Chadi G; Silva C; Maximino JR; Fuxe K; da Silva GO Brain Res; 2008 Jan; 1190():23-38. PubMed ID: 18086466 [TBL] [Abstract][Full Text] [Related]
15. Regional heterogeneity of dopaminergic deficits in vervet monkey striatum and substantia nigra after methamphetamine exposure. Harvey DC; Laćan G; Melegan WP Exp Brain Res; 2000 Aug; 133(3):349-58. PubMed ID: 10958525 [TBL] [Abstract][Full Text] [Related]
16. Elevated D3 dopamine receptor mRNA in dopaminergic and dopaminoceptive regions of the rat brain in response to morphine. Spangler R; Goddard NL; Avena NM; Hoebel BG; Leibowitz SF Brain Res Mol Brain Res; 2003 Mar; 111(1-2):74-83. PubMed ID: 12654507 [TBL] [Abstract][Full Text] [Related]
17. Methamphetamine and human immunodeficiency virus protein Tat synergize to destroy dopaminergic terminals in the rat striatum. Theodore S; Cass WA; Maragos WF Neuroscience; 2006 Feb; 137(3):925-35. PubMed ID: 16338084 [TBL] [Abstract][Full Text] [Related]
18. Molecular neuroadaptations in the accumbens and ventral tegmental area during the first 90 days of forced abstinence from cocaine self-administration in rats. Lu L; Grimm JW; Shaham Y; Hope BT J Neurochem; 2003 Jun; 85(6):1604-13. PubMed ID: 12787079 [TBL] [Abstract][Full Text] [Related]
19. Effect of 1,2,3,4,-tetrahydroisoquinoline administration under conditions of CYP2D inhibition on dopamine metabolism, level of tyrosine hydroxylase protein and the binding of [3H]GBR 12,935 to dopamine transporter in the rat nigrostriatal, dopaminergic system. Lorenc-Koci E; Antkiewicz-Michaluk L; Wardas J; Zapała M; Wierońska J Brain Res; 2004 May; 1009(1-2):67-81. PubMed ID: 15120584 [TBL] [Abstract][Full Text] [Related]
20. Methamphetamine-induced loss of striatal dopamine innervation in BDNF heterozygote mice does not further reduce D3 receptor concentrations. Joyce JN; Renish L; Osredkar T; Walro JM; Kucera J; Dluzen DE Synapse; 2004 Apr; 52(1):11-9. PubMed ID: 14755628 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]